You have 9 free searches left this month | for more free features.

lymphopenia

Showing 1 - 25 of 2,499

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

or Prognostic Risk Factor for Disease Severity in Elderly

Completed
  • Lymphopenia
  • +2 more
  • observation no intervention
  • Brussel, Belgium
    UZ brussel
Jan 30, 2023

Idiopathic CD4 Lymphopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Recombinant human

Not yet recruiting
  • Idiopathic CD4 Lymphopenia
  • Recombinant human interleukin (IL) 7-hyFc
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Stroke-induced Immunodepression in Neurorehabilitation

Completed
  • Stroke
  • +2 more
  • Neurorehabilitation
  • Pavia, Italy
    Headache Science & Neurorehabilitation Center
Jun 1, 2023

Progressive Multifocal Leukoencephalopathy Trial run by the NINDS (NT-I7)

Recruiting
  • Progressive Multifocal Leukoencephalopathy
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 2, 2022

Adenosine Deaminase Enzyme Deficiency in Lymphopenia and/or

Enrolling by invitation
  • Adenosine Deaminase Deficiency
  • ADENOSINE DEAMINASE TEST
  • Konya, Meram, Turkey
    Konya Necmettin Erbakan University
Mar 18, 2022

CD8+ T-cell PET/CT Imaging in COVID-19 Patients

Recruiting
  • Lymphopenia Due to COVID-19
  • +2 more
  • [89Zr]Df-IAB22M2C PET/CT scan
  • Nijmegen, Gelderland, Netherlands
    Radboud university medical center
Jun 2, 2022

Covid19, Lymphopenia Trial in Shenyang (nicotinamide)

Completed
  • Covid19
  • Lymphopenia
  • Shenyang, Liaoning, China
    General Hospital of Northern Theater Command
Oct 29, 2021

Malignant Tumors of Brain Trial in Durham (tetanus toxoid, therapeutic autologous dendritic cells, therapeutic autologous

Active, not recruiting
  • Malignant Neoplasms of Brain
  • tetanus toxoid
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Aug 16, 2022

Natural History of Idiopathic CD4+ Lymphocytopenia

Recruiting
  • Idiopathic CD4+ Lymphocytopenia
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 18, 2022

    Idiopathic CD4 T Cell Lymphocytopenia Trial run by the NIAID (Gardasil 9)

    Recruiting
    • Idiopathic CD4 T Cell Lymphocytopenia
    • Gardasil 9
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 10, 2023

    Idiopathic CD4-Positive, T-Lymphocytopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

    Recruiting
    • Idiopathic CD4-Positive
    • T-Lymphocytopenia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 21, 2023

    Enzyme Deficiency in Pulmonology Clinics (ADA)

    Active, not recruiting
    • Bronchiectasis
    • +2 more
    • adenosine deaminase enzyme deficiency test
    • Ankara, Mamak, Turkey
      Ankara University Medical Faculty
    Mar 18, 2022

    Solid Tumor Malignancies Trial in Houston (Autologous lymphocyte infusion (ALI))

    Recruiting
    • Solid Tumor Malignancies
    • Autologous lymphocyte infusion (ALI)
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 14, 2022

    Lymphocyte Reconstitution After Lymphopenia in Participants

    Completed
    • Multiple Sclerosis
    • Multiple Sclerosis, Relapsing-Remitting
    • Dimethyl fumarate
    • Amiens, France
    • +31 more
    Oct 18, 2021

    Malignant Tumors Brain Trial in Durham (RNA-loaded dendritic cell vaccine, basiliximab)

    Completed
    • Malignant Neoplasms Brain
    • Durham, North Carolina
      Duke University Medical Center
    Mar 8, 2021

    Breast Cancer, Cancer, Therapy-Related, Chemo Effect Trial in Xi'an (Transcutaneous vagus nerve stimulation)

    Recruiting
    • Breast Cancer
    • +3 more
    • Transcutaneous vagus nerve stimulation
    • Xi'an, Shaanxi, China
      Xidian University
    Sep 27, 2021

    Corona Virus Infection Trial in Madrid (T memory cells and NK cells)

    Recruiting
    • Corona Virus Infection
    • T memory cells and NK cells
    • Madrid, Spain
      Hospital Universitario La Paz
    Oct 14, 2020

    Human Immunodeficiency Virus (HIV) Testing

    Completed
    • HIV Seropositivity
    • CD4+ T Lymphocytopenia
    • Medical record review
    • Jena, Thuringia, Germany
      University Hospital Jena
    Aug 30, 2021

    COVID-19, Lymphocytopenia Trial in Brazil (Interleukin-7, PLACEBO)

    Terminated
    • COVID-19
    • Lymphocytopenia
    • Porto Alegre, RIO Grande DO SUL, Brazil
    • +5 more
    Mar 30, 2022

    Postoperative Lymphopenia as Risk Factor for Postoperative

    Completed
    • Cancer of the Digestive System
    • Thoracic Diseases
    • Collection of plasma cell rate
    • Angers, France
    • +19 more
    Jan 15, 2021

    COVID-19, Lymphocytopenia Trial in United Kingdom (Interleukin-7, Placebos)

    Terminated
    • COVID-19
    • Lymphocytopenia
    • Birmingham, United Kingdom
    • +12 more
    Mar 30, 2022

    Glioblastoma, Gliosarcoma Trial in Durham (EGFRvIII CAR T cells)

    Terminated
    • Glioblastoma
    • Gliosarcoma
    • EGFRvIII CAR T cells
    • Durham, North Carolina
      The Preston Robert Tisch Brain Tumor Center at Duke
    Jul 8, 2020

    HIV-1-infection, CD4+ T Lymphocytopenia, Immune Deficiency Trial in Ciudad de México (Pyridostigmine Bromide, Placebo)

    Suspended
    • HIV-1-infection
    • +3 more
    • Pyridostigmine Bromide
    • Placebo
    • Ciudad de México, Tlalpan, Mexico
      Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
    Apr 8, 2020

    Investigation of ADA Enzyme Deficiency

    Enrolling by invitation
    • Adenosine Deaminase Deficiency
    • adenosine deaminase test
    • Ankara, Mamak, Turkey
      Ankara Üniversitesi Tıp Fakültesi
    Mar 18, 2022

    Lung Cancer Trial in Nashville (Evidence-based radiation dose limitation to the vertebral bone marrow)

    Not yet recruiting
    • Lung Cancer
    • Evidence-based radiation dose limitation to the vertebral bone marrow
    • Nashville, Tennessee
      Vanderbilt-Ingram Service for Timely Access
    Jul 1, 2022